Evidence map›Paper›PMID 41629788›Full record

ArticleBMC medical research methodology2026

Two-level non-regular fractional factorial designs for public health studies.

Ming-Chung Chang, Weng Kee Wong

Abstract read
In one paragraph

Article in BMC medical research methodology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ming-Chung ChangInstitute of Statistical Science, Academia Sinica, Taipei, Taiwan.
Weng Kee WongDepartment of Biostatistics, University of California at Los Angeles, Los Angeles, CA , 90095, USA. wkwong@ucla.edu.

Funding

Ministry of Education MOE-108-YSFMS-0004-012-P1
6 · The paper itself

Abstract

This paper demonstrates the advantages of two-level non-regular fractional factorial designs for efficiently identifying influential factors in public health studies. We show how to construct smaller non-regular designs that can reliably estimate main effects and two-factor interactions in multi-factor studies, which are common in public health research. After some background information on non-regular designs and orthogonal arrays, we use real applications to support our claim. The applications include a behavioral intervention study (location/dates unreported), a drug combination trial (UCLA Micro Systems Laboratories, dates unreported), and a non-pharmaceutical Intervention study for influenza (agent-based simulation, dates unreported). We also provide resources on how to construct an appropriate non-regular design for a given problem. Our results from the three case studies show that smaller non-regular designs can identify key factors as reliably as the larger regular designs and they can require as much as 25% fewer runs, thereby reducing the study costs without sacrificing statistical precision in the inference The conclusion is that two-level regular designs are commonly used in public health studies but two-level non-regular designs can improve efficiency in screening multiple environmental, social, and behavioral factors, conserve resources and expedite discovery of evidence-based intervention effects. More specifically, two-level non-regular fractional factorial designs are more practical as they can be more flexible, cost efficient and provide just as reliable estimates as regular full or fractional factorial designs for a public health study with many interacting factors.

Indexed as

Public HealthResearch DesignFactor Analysis, StatisticalHumansInfluenza, HumanConfounderFactors’ interactionsHidden projection propertyOrthogonal array

Identifiers

PMID41629788
PMCPMC12954941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.